IDH1 and adrenal cortex carcinoma: IDH1 R132H immunohistochemical staining correlated with a better prognosis among ACC patients, but did not distinguish between local and metastasized tumors. Paclitaxel reduces the activation of STMN1 and significantly decreases cell migration and invasion in ACC cell lines.